Smoore International Releases 2024 ESG Report with Innovations Update

Apr.14.2025
Smoore International Releases 2024 ESG Report with Innovations Update
Smoore International releases 2024 ESG report, showcasing R&D investment and technological innovations in the electronic vaping industry.

Recently, Smoore International Holdings Limited (06969.HK, "Smoore International") released its "2024 Environmental, Social and Governance Report". The report contains information on the company's annual progress in product and technology innovation. Data from the report shows that Smoore invested approximately 1.57 billion RMB in research and development in 2024, with 1609 R&D personnel. The company has established a research and development system including research institutes, technology centers, product development teams, and technology industrialization centers.

 

Smoore International Releases 2024 ESG Report with Innovations Update
ESG report contents | Image source: 2024 Environmental, Social, and Governance Report

 

The report by Firsts found new developments in the field of electronic atomization technology in the year 2024.

 

Smoore International Releases 2024 ESG Report with Innovations Update
ESG Report Content | Image Source: 2024 Environmental, Social, and Governance Report.

 

FEELM technology platform: POWER ALPHA 2.0 version supports over 15,000 puffs, with a battery energy density reportedly increased by 40% and a 70% reduction in self-discharge rate. 

The FEELM Turbo ceramic core solution is said to increase flavor intensity by 200%, vapor production by 80%, and puff count by over 30%. 

FEELM Pro brings two different series of high puff count solutions: the TPD compliant 5000 puff solution TANKER and the TPD compliant 3200 puff four-in-one solution QUAD SHOT Pro.

 

Smoore International Releases 2024 ESG Report with Innovations Update
ESG report contents | Image source: 2024 Environmental, Social, and Governance Report

 

VAPORESSO, a self-owned brand, has launched the XROS, LUXE, ECO, and ARMOUR series products. The company has also introduced the VIBE product platform, with a focus on providing a similar taste and ease of use as disposable products, along with stylish design. 

 

The taste emphasizes delicacy, richness, and consistency; ease of use emphasizes large capacity, adjustability, easy pod replacement, and strong battery life; the design style aims for a young and trendy look, incorporating integrated design and screen display technology. 

 

The report notes that VAPORESSO products have won several awards, including the MUSE Design Award, London Design Award, IDA International Design Award, French Bilateral Design Award, German Design Award, and International CMF Design Award.

 

Smoore International Releases 2024 ESG Report with Innovations Update
ESG report contents | Image source: 2024 Environmental, Social, and Governance report

 

In other areas of atomization applications, the report disclosed the following information:

 

HNB (Heated Tobacco Product)/Hybrid/e-cigarette product: The MiEE product combines heating tobacco and vaporization functions, using plant extract technology that is compatible with over 80% of heating sticks. The report states that this product reduces harmful organic compounds by 1.97 times compared to other HTP products, improves performance by 30%, and increases nicotine delivery by 50%.

 

Moyal launched its MOYAL Rain brand in 2024, featuring TPS transdermal technology to aerosolize high-viscosity essence for skin penetration. The product line includes both consumer and professional-grade devices (2B+2C). 

 

In the field of aerosolized medicine, its subsidiary Transpire Bio completed the introduction of inhalation devices for asthma and COPD, with key indicators meeting European and American regulatory requirements. Collaborations with international pharmaceutical companies have been established to advance the development of integrated medications with inhalation delivery devices (2B+2C). 

 

The report also highlights an iF Design Award-winning cartridge-based product, utilizing 100% tobacco extract and incorporating a rotating pop-up hygienic mouthpiece.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
The U.S. Food and Drug Administration (FDA) has named Jessica Zeller director of the Center for Tobacco Products' (CTP) Office of Compliance and Enforcement (OCE), effective November 1, 2026. Zeller, the office's inaugural deputy director, returns from medical device manufacturer Edwards Lifesciences with more than 20 years of regulatory and legal experience. The appointment follows CTP leadership changes and adjustments to tobacco regulation. Bret Koplow became permanent CTP director in September; the FDA revised enforcement priorities for unauthorized e-cigarettes and nicotine pouches in May and announced faster PMTA review procedures. On September 28, the agency said it would evaluate changes to the existing PMTA regulatory framework, including potential rulemaking to replace it.
FDA
Oct.20 by 2Firsts Perspectives
Ireland Raises Nicotine Product Taxes Again as Cigarettes Gain €1 and Vape Duty Is Set to Jump 40%
Ireland Raises Nicotine Product Taxes Again as Cigarettes Gain €1 and Vape Duty Is Set to Jump 40%
Ireland has increased tobacco excise under Budget 2027 and announced a further rise in its E-liquid Products Tax. From Oct. 7, the tax burden on a pack of 20 cigarettes in the most popular price category increased by €1, with pro-rata increases on other tobacco products. The government plans to raise EPT from €0.50 to €0.70 per millilitre from Jan. 1, 2027, a 40% increase applying to both nicotine-containing and nicotine-free e-liquids. The tobacco duty increase is expected to raise about €63.1 million in a full year.
Regulations
Oct.09
Germany's Four-Year Tobacco Tax Plan Heads to Parliament as BAT, JTI and PMI Push for Changes
Germany's Four-Year Tobacco Tax Plan Heads to Parliament as BAT, JTI and PMI Push for Changes
Germany's parliament is scheduled to hold a first reading of amendments to the Tobacco Tax Act on September 24. The government plans annual tax increases from 2027 through 2030 covering cigarettes, heated tobacco, vaping liquids and other categories. It expects the reform to generate €756 million in additional revenue in 2027, rising to €3.589 billion in additional annual revenue by 2030. Ahead of the parliamentary debate, the German Association of the Tobacco Industry and Novel Products, or BVTE, launched the "Tabaksteuer mit Augenmaß" campaign backed by BAT, JTI, Philip Morris, Reemtsma and wholesale and retail groups.
Sep.23
Japan Survey Finds 49.5% Would Cut Tobacco Use if Prices Rise, 64.6% Show Interest in Nicotine-Free Alternatives
Japan Survey Finds 49.5% Would Cut Tobacco Use if Prices Rise, 64.6% Show Interest in Nicotine-Free Alternatives
A September online survey commissioned by Japanese smoking-accessories company Lightec found that 49.5% of respondents would consider reducing tobacco use if prices rose further, while 25.1% would consider switching to cheaper brands and 14.5% would consider using or combining alternatives such as vapes and nicotine-free herbal sticks. Another 64.6% expressed some level of interest in such alternatives. The survey covered 1,088 respondents aged 20 to 70 and was conducted by a company that sells NICOLESS nicotine-free vaping and herbal-stick products, meaning its findings should not be treated as representative of Japan's smoking population.
DATA
Oct.12
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Philip Morris International (PMI) has launched ZYN Melts in the UK, introducing a fully dissolvable oral nicotine tablet format alongside the brand's existing nicotine pouches. The range includes Cool Mint and Peppermint, each offered at 1mg and 2mg of nicotine per tablet, creating four SKUs. Each can contains 20 tablets and is priced at £6.50 in the UK. Unlike ZYN nicotine pouches, Melts are placed between the upper lip and gum and dissolve completely during use.
News
Sep.29 by 2Firsts Perspectives
Why Does JPMorgan Favor BAT Over Philip Morris Despite Forecasting Slower Growth of 3.9% Versus 6.2%?
Why Does JPMorgan Favor BAT Over Philip Morris Despite Forecasting Slower Growth of 3.9% Versus 6.2%?
JPMorgan resumed equity research coverage of British American Tobacco (BAT), Philip Morris International (PMI) and Imperial Brands in November 2026, assigning BAT an Overweight rating and the other two companies Neutral ratings. The bank forecasts like-for-like sales growth of 3.9% for BAT and 6.2% for PMI in 2027, but estimates the two companies will trade at approximately 11 times and 21 times 2027 earnings, respectively. JPMorgan cited BAT's improving position in US nicotine pouches and vaping products as a driver of its investment outlook. BAT reported a 220% constant-currency increase in US modern oral nicotine revenue in the first half of 2026, while PMI's ZYN US shipments returned to growth in the third quarter. Imperial expects NGPs to represent 4% to 5% of sales and has expanded its oral portfolio through acquisitions.
Capital Markets
Nov.12